"Virulence Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486)
| Descriptor ID |
D037521
|
| MeSH Number(s) |
D23.946.896
|
| Concept/Terms |
Virulence Factors- Virulence Factors
- Factors, Virulence
- Pathogenicity Factors
- Factors, Pathogenicity
|
Below are MeSH descriptors whose meaning is more general than "Virulence Factors".
Below are MeSH descriptors whose meaning is more specific than "Virulence Factors".
This graph shows the total number of publications written about "Virulence Factors" by people in this website by year, and whether "Virulence Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Virulence Factors" by people in Profiles.
-
Pseudomonas aeruginosa Cytotoxins: Mechanisms of Cytotoxicity and Impact on Inflammatory Responses. Cells. 2023 01 03; 12(1).
-
Comparison of an ST80 MRSA strain from the USA with European ST80 strains. J Antimicrob Chemother. 2015 Mar; 70(3):664-9.
-
Delineating the Epidemiology-Host-Microbe Relationship for Methicillin-Resistant Staphylococcus aureus Infection. J Infect Dis. 2015 Jun 15; 211(12):1857-9.
-
Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia. mBio. 2013 Mar 12; 4(2):e00032-13.
-
Epidemiology and pathogenesis of Pseudomonas aeruginosa infections. Clin Lab Sci. 2011; 24(1):43-6.
-
Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A. Infect Immun. 1986 Jun; 52(3):756-62.
-
Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7.
-
Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitro. Infect Immun. 1982 Oct; 38(1):206-11.
-
Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization. J Infect Dis. 1982 May; 145(5):688-98.